IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $204,000 | -61.4% | 12,708 | -69.6% | 0.01% | -60.9% |
| Q1 2017 | $528,000 | +543.9% | 41,750 | +571.1% | 0.02% | +360.0% |
| Q4 2016 | $82,000 | -41.4% | 6,221 | +4.8% | 0.01% | -44.4% |
| Q3 2016 | $140,000 | -3.4% | 5,934 | +30.4% | 0.01% | -25.0% |
| Q1 2016 | $145,000 | +150.0% | 4,550 | +171.6% | 0.01% | +200.0% |
| Q3 2015 | $58,000 | -58.9% | 1,675 | -44.6% | 0.00% | -75.0% |
| Q1 2015 | $141,000 | – | 3,024 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |